Once the most common treatment for indolent non-Hodgkin’s Lymphoma, the combination chemotherapy known as CHOP is rapidly falling to the wayside in Germany – replaced by bendamustine (Treanda), frequently combined with rituximab (Rituxan), researchers reported here.

via New Combo Replaces CHOP for Lymphoma.

NOTE the commercial interests disclosures at the end of the original article.